IVF Stock Summary and Trading Ideas (Invo Fertility | NASDAQ:IVF)

INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.

Invo Fertility trades on the NASDAQ stock market under the symbol IVF.

As of August 17, 2026, IVF stock price climbed to $1.53 with 57,285,995 million shares trading.

IVF has a beta of -0.48, meaning it tends to be less sensitive to market movements. IVF has a correlation of 0.00 to the broad based SPY ETF.

IVF has a market cap of $2.73 million. This is considered a Sub-Micro Cap stock.

Last quarter Invo Fertility reported $2 million in Revenue and -$3.38 earnings per share. This beat revenue expectation by $35,000 and exceeded earnings estimates by $6.62.

IVF has underperformed the market in the last year with a return of -97.8%, while the SPY ETF gained +21.0%. In the last 3 month period, IVF fell short of the market, returning -1.9%, while SPY returned +3.5%. However, in the most recent 2 weeks IVF has outperformed the stock market by returning +63.3%, while SPY returned +3.4%.

IVF support price is $.92 and resistance is $1.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVF shares will trade within this expected range on the day.